55 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
10 May 22
Aurinia Reports First Quarter 2022 Financial and Operational Results
6:06am
on assumptions regarding the impact of COVID-19 on the current business environment and represents an increase of more than 150 to 200% in net revenue from sales
8-K
EX-99.1
jal9q96uf8wgr4zl9u2b
28 Feb 22
Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates
6:08am
S-3ASR
EX-1.2
y596ftzj5
19 Nov 21
Automatic shelf registration
5:04pm
S-3ASR
f0f3xjdd
19 Nov 21
Automatic shelf registration
5:04pm
DEF 14A
fub4807l
10 May 21
Definitive proxy
4:06pm
PRE 14A
rxw1jmx
27 Apr 21
Preliminary proxy
4:32pm
10-K
EX-10.17
047io cw7xcb
24 Feb 21
Annual report
4:09pm
10-K
EX-10.6
sb9w2jnu
24 Feb 21
Annual report
4:09pm
10-K
EX-10.7
za0wc4u3ana6l4sd612x
24 Feb 21
Annual report
4:09pm
10-K
q5cxa
24 Feb 21
Annual report
4:09pm
10-K
EX-10.8
6tqde8 4zb65xvoc7
24 Feb 21
Annual report
4:09pm
6-K
EX-99.2
qdd0y4xcktaj
30 Dec 20
Material Change Report
5:30pm
6-K
EX-99.1
9zr3 ti8h
16 Dec 20
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.2
5jpvkryxnytd56igf
10 Nov 20
Current report (foreign)
4:05pm
6-K
EX-99.2
4vanwedt3e90rf2hlz
11 Aug 20
Current report (foreign)
4:04pm